treatment option

Leptin Increasing Sympathetic Nerve Outflow in Obesity: A Cure for Obesity or a Potential Contributor to Metabolic Syndrome?

Published May 24, 2013

Leptin increasing sympathetic nerve outflow in obesity: A cure for obesity or a potential contributor to metabolic syndrome?

Adipocyte. 2012 Jul 1; 1(3): 177-181
Simonds SE, Cowley MA, Enriori PJ

Obesity is a global problem and effective drug therapy… Continue reading →

Non-Destructively Shattered Mesoporous Silica for Protein Drug Delivery.

Published May 21, 2013

Non-destructively shattered mesoporous silica for protein drug delivery.

Microporous Mesoporous Mater. 2013 Jul 15; 175: 157-160
Lei C, Chen B, Li X, Qi W, Liu J

Mesoporous silicas have been extensively used for entrapping small chemical molecules and biomacromolecules… Continue reading →

Prospective, Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With Mood Disorders.

Published May 21, 2013

Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders.

Patient Prefer Adherence. 2013; 7: 411-417
Sajatovic M, Thompson TR, Nanry K, Edwards S, Manjunath R

Lamotrigine is an anticonvulsant drug indicated… Continue reading →

The Face of Appearance-Related Social Pressure: Gender, Age and Body Mass Variations in Peer and Parental Pressure During Adolescence.

Published May 18, 2013

The face of appearance-related social pressure: gender, age and body mass Variations in peer and parental pressure during adolescence.

Child Adolesc Psychiatry Ment Health. 2013 May 17; 7(1): 16
Helfert S, Warschburger P

BACKGROUND: Appearance-related social pressure plays an… Continue reading →

Minimal Peptides Can Enhance Nanoparticle Drug Delivery by Inhibiting Phagocytic Clearance.

Published May 18, 2013

Minimal peptides can enhance nanoparticle drug delivery by inhibiting phagocytic clearance.

Nanomedicine (Lond). 2013 Apr; 8(4): 519
Potticary J

HubMed – drug

Synthesis and enhanced thermal stability of albumins@alumina: towards injectable sol-gel materials.

Chem Commun (Camb). 2013… Continue reading →

Mucosal and Systemic Immune Responses to Mycobacterium Tuberculosis Antigen 85A Following Its Co-Delivery With CpG, MPLA or LTB to the Lungs in Mice.

Published May 16, 2013

Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice.

PLoS One. 2013; 8(5): e63344
Todoroff J, Lemaire MM, Fillee C, Jurion F, Renauld JC, Huygen… Continue reading →

What Is “Usual Care” in Dysphagia Rehabilitation: A Survey of USA Dysphagia Practice Patterns.

Published May 15, 2013

What is “Usual Care” in Dysphagia Rehabilitation: A Survey of USA Dysphagia Practice Patterns.

Dysphagia. 2013 May 14;
Carnaby GD, Harenberg L

The scope of dysphagia rehabilitation has been expanding. Therapeutic approaches have begun to move away from the… Continue reading →

A Cross-Cultural Validation of the Clinician Administered PTSD Scale for Children and Adolescents in a Dutch Population.

Published May 15, 2013

A cross-cultural validation of the Clinician Administered PTSD Scale for Children and Adolescents in a Dutch population.

Eur J Psychotraumatol. 2013; 4:
Diehle J, de Roos C, Boer F, Lindauer RJ

Trauma-focused interventions for children could be administered more… Continue reading →

Who Do I Need to See for Possible Depression- Psychiatrist or Doctor?

Published May 13, 2013

by benchilada

Question by Renna: Who do I need to see for possible depression- Psychiatrist or Doctor?
I think I might be suffering from depression, but I’m still a bit confused on who I need to see for treatment (at… Continue reading →

Anorexic: I Just Ate a Cupcake, I Feel Like a Failure..?